Keywords: comgenex, boosts, albany, molecular, revenues, hungarian, drug

Comgenex boosts Albany Molecular revenues

Article | 29 May 2006

ComGenex, the Hungarian drug discovery enterprise acquired by US firm Albany Molecular Research has contributed $500,000 to AMR's first-quarter 2006 contract revenues ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Drug Discovery

Go to company listing